Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
clopidogrel (plavix) (2 trials)
prasugrel (effient) (2 trials)
ticagrelor (brilinta) (1 trial)
Acute Coronary Syndrome (Phase 4)
Arteriosclerosis (Phase 4)
Cardiovascular Diseases (Phase 4)
Coronary Artery Disease (Phase 4)
Ischemia (Phase 4)
Myocardial Ischemia (Phase 4)
Syndrome (Phase 4)
Trials (2 total)
Trial APIs (3 total)